# Ajinomoto Co., Inc. · 66-66 · JAPAN — FDA import alert red lists: firms subject to detention without physical examination

For Ajinomoto Co., Inc. · 66-66 · JAPAN, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is JAPAN; product is L-Dopa; product code is 62 J - S 09 Levodopa (Anti-Parkinsonian), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is Ajinomoto (Kabu) Honsha , 1 Chome; Kyobashi , Chuo, Tokyo JAPAN, verified against its source on 2026-09-16.

- **Firm:** Ajinomoto Co., Inc. _(verified: appears in the quote below)_
- **Import alert:** 66-66
- **Import alert name:** "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- **Country:** JAPAN _(verified: appears in the quote below)_
- **Address:** Ajinomoto (Kabu) Honsha , 1 Chome; Kyobashi , Chuo, Tokyo JAPAN _(verified: appears in the quote below)_
- **Date published:** 09/30/2009 _(verified: appears in the quote below)_
- **Product code:** 62 J - S 09 Levodopa (Anti-Parkinsonian), Active Pharm Ingred/Chems for Further Manuf _(verified: appears in the quote below)_
- **Product:** L-Dopa _(verified: appears in the quote below)_
- **FDA notes:** 11/2/2000 _(verified: appears in the quote below)_

## What the source says

> Ajinomoto Co., Inc. Date Published : 09/30/2009 Ajinomoto (Kabu) Honsha , 1 Chome; Kyobashi , Chuo, Tokyo JAPAN 62 J - S 09 Levodopa (Anti-Parkinsonian), Active Pharm Ingred/Chems for Further Manuf Date Published: 10/09/2018 Desc: L-Dopa Notes: 11/2/2000

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_202.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).